Lingjun Wang
6PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 11, 2025
Effects of orelabrutinib, a BTK inhibitor, on antibody-mediated platelet destruction in primary immune thrombocytopenia.Tian-Shu Yu, Shou-Qing Han, Ling-Jun Wang
|Apr 04, 2024
Platelet-derived TGF-β1 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia.Lingjun Wang, Haoyi Wang, Mingfang Zhu
|Aug 29, 2022
Low-dose decitabine modulates myeloid-derived suppressor cell fitness via LKB1 in immune thrombocytopenia.Xiaofei Ni, Lingjun Wang, Haoyi Wang
|Feb 17, 2022
Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis.Qidi Chen, Min Xin, Lingjun Wang
|Jan 20, 2022
Single-dose versus low-dose rituximab in corticosteroid-resistant or relapsed ITP: A multicenter, randomized, controlled study.Xiaofei Ni, Daqi Li, Chenglu Yuan
|Dec 02, 2021
Significance of anti-HBc serological status in primary immune thrombocytopenia.Lingjun Wang, Lizhen Li, Chaoyang Li
Pageof 1
